Gabriela Barbaglia1, Núria D Adroher2, Gemma Vilagut3, Ronny Bruffaerts4, Brentan Bunting5, José Miguel Caldas de Almeida6, Silvia Florescu7, Giovanni de Girolamo8, Ron de Graaf9, Josep Maria Haro10, Hristo Hinkov11, Vivianne Kovess-Masfety12, Herbert Matschinger13, Jordi Alonso14. 1. Agency for Health and Quality Assessment of Catalonia (AQuAS), Barcelona, Spain; Universitat Pompeu Fabra, Department of Experimental Sciences and Health, Faculty of Public Health and Education in Health Sciences, Barcelona, Spain. 2. University of Lucerne, Faculty of Humanities and Social Sciences, Department of Health Science and Health Policy, Lucerne, Switzerland. 3. Universitat Pompeu Fabra, Department of Experimental Sciences and Health, Faculty of Public Health and Education in Health Sciences, Barcelona, Spain; Health Services Research Unit, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain. 4. Universitair Psychiatrisch Centrum, KU Leuven (UPC-KUL), Leuven, Belgium. 5. University of Ulster, School of Psychology, Research Institute of Psychology, Northern Ireland, United Kingdom. 6. Universidade Nova de Lisboa, Faculty of Medical Sciences, Mental Health Department, Lisbon Portugal. 7. National School of Public Health, Management and Professional Development, Bucharest, Romania. 8. Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. 9. Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands. 10. Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, Sant Boi de Llobregat (Barcelona), España; CIBER en Salud Mental (CIBERSAM), Spain. 11. National Center for Public Health Protection, Department of Mental Health, Sofia, Bulgaria. 12. Université Paris Descartes, Department of Epidemiology, Evaluation and Health policies, Paris, France. 13. University of Leizpig, Department of Social Medicine, Occupational Health and Public Health, Leipzig, Germany. 14. Universitat Pompeu Fabra, Department of Experimental Sciences and Health, Faculty of Public Health and Education in Health Sciences, Barcelona, Spain; Health Services Research Unit, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: jalonso@imim.es.
Abstract
OBJECTIVE: To describe the distribution of role limitation in the European population aged 18-64 years and to examine the contribution of health conditions to role limitation using a public-health approach. METHODS: Representative samples of the adult general population (n=13,666) aged 18-64 years from 10 European countries of the World Mental Health (WMH) Surveys Initiative, grouped into three regions: Central-Western, Southern and Central-Eastern. The Composite International Diagnostic Interview (CIDI 3.0) was used to assess six mental disorders and standard checklists for seven physical conditions. Days with full and with partial role limitation in the month previous to the interview were reported (WMH-WHODAS). Population Attributable Fraction (PAFs) of full and partial role limitation were estimated. RESULTS: Health conditions explained a large proportion of full role limitation (PAF=62.6%) and somewhat less of partial role limitation (46.6%). Chronic pain was the single condition that consistently contributed to explain both disability measures in all European Regions. Mental disorders were the most important contributors to full and partial role limitation in Central-Western and Southern Europe. In Central-Eastern Europe, where mental disorders were less prevalent, physical conditions, especially cardiovascular diseases, were the highest contributors to disability. CONCLUSION: The contribution of health conditions to role limitation in the three European regions studied is high. Mental disorders are associated with the largest impact in most of the regions. There is a need for mainstreaming disability in the public health agenda to reduce the role limitation associated with health conditions. The cross-regional differences found require further investigation.
OBJECTIVE: To describe the distribution of role limitation in the European population aged 18-64 years and to examine the contribution of health conditions to role limitation using a public-health approach. METHODS: Representative samples of the adult general population (n=13,666) aged 18-64 years from 10 European countries of the World Mental Health (WMH) Surveys Initiative, grouped into three regions: Central-Western, Southern and Central-Eastern. The Composite International Diagnostic Interview (CIDI 3.0) was used to assess six mental disorders and standard checklists for seven physical conditions. Days with full and with partial role limitation in the month previous to the interview were reported (WMH-WHODAS). Population Attributable Fraction (PAFs) of full and partial role limitation were estimated. RESULTS: Health conditions explained a large proportion of full role limitation (PAF=62.6%) and somewhat less of partial role limitation (46.6%). Chronic pain was the single condition that consistently contributed to explain both disability measures in all European Regions. Mental disorders were the most important contributors to full and partial role limitation in Central-Western and Southern Europe. In Central-Eastern Europe, where mental disorders were less prevalent, physical conditions, especially cardiovascular diseases, were the highest contributors to disability. CONCLUSION: The contribution of health conditions to role limitation in the three European regions studied is high. Mental disorders are associated with the largest impact in most of the regions. There is a need for mainstreaming disability in the public health agenda to reduce the role limitation associated with health conditions. The cross-regional differences found require further investigation.
Keywords:
Common health conditions; Disability; Discapacidad; Population attributable risk; Proporción atribuible de riesgo; Role limitation; Trastornos físicos; Trastornos mentales
Authors: Antonio Ojeda; Andrea Calvo; Tomas Cuñat; Ricard Mellado-Artigas; Oscar Comino-Trinidad; Jorge Aliaga; Marilyn Arias; Carlos Ferrando; Graciela Martinez-Pallí; Christian Dürsteler Journal: Eur J Pain Date: 2021-12-15 Impact factor: 3.651
Authors: Ana Antunes; Diana Frasquilho; Sofia Azeredo-Lopes; Manuela Silva; Graça Cardoso; José Miguel Caldas-de-Almeida Journal: Int J Equity Health Date: 2018-08-07
Authors: Miguel Angel Galan-Martin; Federico Montero-Cuadrado; Enrique Lluch-Girbes; María Carmen Coca-López; Agustín Mayo-Iscar; Antonio Cuesta-Vargas Journal: J Clin Med Date: 2020-04-22 Impact factor: 4.241